| Literature DB >> 26476236 |
Isabelle Le Ber1, Anne De Septenville2, Stéphanie Millecamps2, Agnès Camuzat2, Paola Caroppo3, Philippe Couratier4, Frédéric Blanc5, Lucette Lacomblez6, François Sellal7, Marie-Céline Fleury8, Vincent Meininger9, Cécile Cazeneuve10, Fabienne Clot11, Olivier Flabeau12, Eric LeGuern13, Alexis Brice14.
Abstract
TANK1-binding kinase 1 (TBK1) has been recently identified as a new amyotrophic lateral sclerosis (ALS) gene. Loss-of-function (LoF) mutations in TBK1 could be responsible for 0.4%-4% of ALS. Considering the strong genetic overlap existing between frontotemporal dementia (FTD) and ALS, we have evaluated the frequencies of TBK1 mutations in a cohort of French FTD and of ALS patients. We identified 5 LoF mutations, in 4 FTD-ALS and 1 ALS patients. We also identified 5 heterozygous missense variants, predicted to be deleterious, in 1 isolated FTD, 1 FTD-ALS, and 3 ALS cases. Our results demonstrate that TBK1 loss-of-function mutations are more frequent in patients with FTD-ALS (10.8%) than in isolated ALS. TBK1 should thus also be sequenced, after exclusion of C9orf72 mutation, in patients presenting FTD, particularly in cases secondarily associated with ALS.Entities:
Keywords: Amyotrophic lateral sclerosis (ALS); Frontotemporal dementia (FTD); Frontotemporal lobar degeneration (FTLD); Loss of function; Optineurin; TBK1
Mesh:
Substances:
Year: 2015 PMID: 26476236 DOI: 10.1016/j.neurobiolaging.2015.08.009
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673